Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.

@article{Kaiho2013OptimizationOS,
  title={Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.},
  author={Yasuhiro Kaiho and Shinichi Yamashita and Yoichi Arai},
  journal={International journal of urology : official journal of the Japanese Urological Association},
  year={2013},
  volume={20 3},
  pages={285-9}
}
Erectile dysfunction after radical prostatectomy is a major complication affecting postoperative quality of life. For early recovery from postoperative erectile dysfunction, attention has focused on penile rehabilitation using vacuum devices, prostaglandin E1 injection into the corpus cavernosum of the penis or transurethral administration, and oral drugs such as phosphodiesterase type 5 inhibitors. Phosphodiesterase type 5 inhibitors have been used clinically based on the results of animal… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 57 references

A comparison of outcomes for interfascial and intrafascial nervesparing radical prostatectomy

P Kallidonis
Urology • 2010

Similar Papers

Loading similar papers…